Archive · 25 Jul 2025
Pharma Stock Soars 20% Amid Market Weakness, Reports Strong Growth
Imagine a company, Tatva Chintan Pharma, doing really well!
Their stock price went up by 20% in one day.
This happened because they made more money; their profits increased, and their sales went up too.
A smart investor also bought a small part of the company, which made other people think the company is doing great.
The company is performing well and is expected to do even better.
This is why the stock price went up, showing that investors believe in the company's future.
Tatva Chintan Pharma Chem's stock rose 20% to a 52-week high.
The company's profit after tax increased by 27.7% to Rs 6.7 crore in Q1 FY26.
EBITDA rose by 37.4% to Rs 17 crore in the same period.
Revenue for the quarter was Rs 117 crore, a 10.8% increase year-over-year.
Investor Mukul Agrawal acquired a 1.28% stake, boosting investor confidence.
- Who
- Tatva Chintan Pharma Chem and investor Mukul Agrawal.
- What
- Tatva Chintan Pharma Chem's stock price increased by 20%.
- When
- On Friday, July 25.
- Where
- BSE.
- Why
- Due to robust financial performance and investor confidence.
- Stock Increase
- 20%
- New 52-week high
- Rs 1,219.90
- Profit After Tax (Q1 FY26)
- Rs 6.7 crore
- EBITDA (Q1 FY26)
- Rs 17 crore
- Revenue (Q1)
- Rs 117 crore
- Stake Acquired
- 1.28%